TOMEI, Paola
 Distribuzione geografica
Continente #
EU - Europa 95
NA - Nord America 83
AS - Asia 63
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 245
Nazione #
US - Stati Uniti d'America 76
IT - Italia 35
FR - Francia 30
VN - Vietnam 23
CN - Cina 13
AT - Austria 9
IE - Irlanda 7
JP - Giappone 7
MX - Messico 7
DE - Germania 6
IN - India 5
KR - Corea 5
TW - Taiwan 4
RU - Federazione Russa 3
AU - Australia 2
PH - Filippine 2
A1 - Anonimo 1
AR - Argentina 1
ES - Italia 1
GB - Regno Unito 1
ID - Indonesia 1
IR - Iran 1
LK - Sri Lanka 1
NL - Olanda 1
RS - Serbia 1
TR - Turchia 1
UA - Ucraina 1
Totale 245
Città #
Dong Ket 20
Ashburn 18
Verona 13
Vienna 9
Beijing 7
Dublin 7
Woodbridge 6
Ann Arbor 5
Hidalgo 5
University Park 5
Mountain View 3
Munich 3
Paris 3
Wilmington 3
Boardman 2
Cambridge 2
Fairfield 2
Jacksonville 2
Lake Forest 2
Malo 2
Mexico 2
Nürnberg 2
Seattle 2
Shanghai 2
Taipei 2
Basking Ridge 1
Belgrade 1
Bensenville 1
Blacktown 1
Bologna 1
Boston 1
Bristol 1
Buenos Aires 1
Chicago 1
Dearborn 1
Delhi 1
Edinburg 1
Eskisehir 1
Frankfurt am Main 1
Fremont 1
Gesualdo 1
Gorizia 1
Groningen 1
Hicksville 1
Jakarta 1
Kolkata 1
Madrid 1
New Delhi 1
New York 1
Osny 1
Padova 1
Pisa 1
San Diego 1
Tehran 1
Tokyo 1
Torino 1
Washington 1
West Orange 1
Wuhan 1
Totale 163
Nome #
Monoclonal antibody therapy and renal transplantation: focus on adverse effects., file e14ff6e3-8753-0209-e053-6605fe0ad24c 76
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets., file e14ff6e4-4c44-0209-e053-6605fe0ad24c 47
Individuazione di nuovi marker diagnostici e target terapeutici potenzialmente utilizzabili nella pratica clinica trapiantologica per minimizzare il processo di fibrosi polmonare indotta dalle alte dosi di everolimus: risultati di uno studio in vitro di mirnomica e trascrittomica., file e14ff6e4-5eb0-0209-e053-6605fe0ad24c 29
Mitochondria: a new therapeutic target in chronic kidney disease., file e14ff6e3-8dd0-0209-e053-6605fe0ad24c 24
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine., file e14ff6e3-910a-0209-e053-6605fe0ad24c 23
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder., file e14ff6e3-8745-0209-e053-6605fe0ad24c 22
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors., file e14ff6e3-8d83-0209-e053-6605fe0ad24c 20
mTOR inhibitors and renal allograft: Yin and Yang., file e14ff6e3-86e5-0209-e053-6605fe0ad24c 2
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients., file e14ff6e3-875b-0209-e053-6605fe0ad24c 2
Post-renal transplant pregnancy: a project to plan carefully, file e14ff6e3-8d49-0209-e053-6605fe0ad24c 1
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation., file e14ff6e3-90ca-0209-e053-6605fe0ad24c 1
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation., file e14ff6e3-90d5-0209-e053-6605fe0ad24c 1
Totale 248
Categoria #
all - tutte 730
article - articoli 602
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 128
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.460


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201934 0 0 0 0 0 0 0 0 0 10 19 5
2019/202049 8 9 5 13 3 2 0 0 0 8 1 0
2020/202127 4 4 0 0 1 0 0 0 0 0 1 17
2021/202222 7 0 2 0 1 2 1 1 2 1 3 2
2022/202329 0 2 1 2 7 8 0 0 0 0 8 1
2023/202440 0 1 8 1 1 9 3 10 4 3 0 0
Totale 248